Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals Ownership Summary
Lexicon Pharmaceuticals is owned by 88.72% institutional investors, 0.98% insiders, and 10.30% retail investors. Artal group is the largest institutional shareholder, holding 42.62% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.
LXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lexicon Pharmaceuticals | 88.72% | 0.98% | 10.30% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 154.73M | 42.62% | $241.39M |
| Fmr | 45.06M | 12.41% | $70.29M |
| Siren | 44.30M | 12.20% | $69.11M |
| Sessa capital im | 17.91M | 4.93% | $27.94M |
| Blackrock | 9.89M | 4.03% | $16.62M |
| Vanguard group | 9.61M | 2.64% | $11.05M |
| Point72 asset management | 7.81M | 2.15% | $12.19M |
| Millennium management | 4.94M | 1.36% | $7.71M |
| Blackrock funding, inc. /de | 3.32M | 0.92% | $5.18M |
| Geode capital management | 3.17M | 0.87% | $4.95M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 154.73M | 23.89% | $241.39M |
| Siren | 44.30M | 1.92% | $69.11M |
| Sessa capital im | 17.91M | 0.51% | $27.94M |
| Quantessence capital | 18.58K | 0.14% | $28.99K |
| Gsa capital partners llp | 930.09K | 0.09% | $1.45M |
| R squared | 67.53K | 0.06% | $105.34K |
| Catalyst funds management pty | 207.90K | 0.05% | $324.32K |
| Hennion & walsh asset management | 848.14K | 0.04% | $1.32M |
| Headlands | 191.32K | 0.03% | $298.46K |
| Tang capital management | 399.70K | 0.03% | $623.53K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Artal group | 154.73M | 23.89% | 18.55M |
| Sessa capital im | 17.91M | 0.51% | 14.91M |
| Point72 asset management | 7.81M | 0.02% | 7.53M |
| Fmr | 45.06M | 0.00% | 7.22M |
| Siren | 44.30M | 1.92% | 5.38M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -11.02M |
| Nea management company | - | - | -2.38M |
| Ameriprise financial | - | - | -2.33M |
| Opaleye management | - | - | -1.88M |
| Bvf inc/il | - | - | -1.69M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 1.33M | 0.00% | 1.33M | $2.08M |
| Mackenzie financial | 772.68K | 0.00% | 772.68K | $1.21M |
| Tang capital management | 399.70K | 0.03% | 399.70K | $623.53K |
| Brevan howard capital management lp | 160.50K | 0.00% | 160.50K | $250.38K |
| Scotia capital | 159.83K | 0.00% | 159.83K | $249.34K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Newedge advisors | -5.00 |
| Federated hermes | -6.00 |
| Capital performance advisors llp | -18.00 |
| Nelson, van denburg & campbell wealth management group | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 137 | 7.87% | 322,086,781 | 23.68% | 88 | 1.73% | 68 | 36.00% | 27 | -32.50% |
| Dec 31, 2025 | 31 | -76.15% | 15,205,811 | -94.10% | 4 | 0.08% | 7 | -85.11% | 8 | -80.00% |
| Sep 30, 2025 | 48 | -60.66% | 14,323,194 | -94.37% | 3 | 0.08% | 11 | -81.03% | 15 | -57.14% |
| Jun 30, 2025 | 126 | -3.82% | 256,258,970 | -3.59% | 70 | 1.31% | 59 | -11.94% | 38 | 18.75% |
| Mar 31, 2025 | 130 | -1.52% | 265,798,118 | -10.70% | 73 | 1.08% | 66 | -5.71% | 33 | 32.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 20.40M | 5.64% | 2.23M |
| Fidelity Growth Compy Commingled Pl S | 21.66M | 4.88% | 696.67K |
| Fidelity Growth Company Fund | 14.83M | 3.34% | 489.90K |
| Vanguard Total Stock Mkt Idx Inv | 6.85M | 1.54% | - |
| Vanguard US Total Market Shares ETF | 3.89M | 1.08% | - |
| Fidelity Growth Company K6 | 4.44M | 1.00% | 109.03K |
| Fidelity Series Growth Company | 3.54M | 0.80% | 127.40K |
| iShares Russell 2000 ETF | 2.88M | 0.79% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.46M | 0.55% | 14.76K |
| Columbia Small Cap Value I A | 1.91M | 0.53% | 497.77K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 25, 2026 | DEBBANE RAYMOND | - | Buy | $2.98K |
| Feb 23, 2026 | DEBBANE RAYMOND | - | Buy | $147.00K |
| Feb 20, 2026 | DEBBANE RAYMOND | - | Buy | $147.79K |
| Feb 19, 2026 | DEBBANE RAYMOND | - | Buy | $71.97K |
| Feb 18, 2026 | DEBBANE RAYMOND | - | Buy | $176.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | 8 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
LXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools